Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-019192

Chief Technical Officer sold 21,493 shares at an average $26.89 ($578,038)

  • Chief Technical Officer acquired 21,493 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Watler Peter K. · Chief Technical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2015-11-20 Exercise or conversion : show line 1 in the form +20,000 $1.42 $28,340 20,000 I
2015-11-20 Sale : show line 2 in the form −20,000 $27.41 $548,178 0 I
2016-05-02 Exercise or conversion : show line 3 in the form +1,493 $2.08 $3,111 1,493 I
2016-05-02 Sale : show line 4 in the form −1,493 $20.00 $29,860 0 I
Open-market sales · 21,493 sh · avg $26.89 · $578,038

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2015-11-20 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −20,000 39,988 I
2016-05-02 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −1,493 55,495 I
Loading xslF345X03/doc4.xml…